Revealed: global funds, from BlackRock to Temasek, back China’s largest biotech firms

    Revealed: global funds, from BlackRock to Temasek, back China’s largest biotech firms

    As Chinese biotech and pharmaceutical firms gain importance on the global stage, foreign investors from sovereign wealth funds to industry players are securing strategic stakes in their future success. International institutional investors have built up significant positions in Chinese biotech firms over the past decade. These positions often approach, and in some cases exceed, the…

    Read More
    Fidelity customers lose 401(k) access. Some call it a 'mind-boggling' power grab. But the company says it's about safety

    Fidelity customers lose 401(k) access. Some call it a ‘mind-boggling’ power grab. But the company says it’s about safety

    As a major investment company and financial technology (fintech) platforms fight over access to client retirement accounts, some customers caught in the middle are discovering that the “K” in 401(k) might just stand for “Keep out.” The retirement rumble escalated recently when Fidelity began enforcing a new policy restricting access for third-party financial advisors, and…

    Read More
    4 Money Moves To Beef Up Retirement Plans

    4 Money Moves To Beef Up Retirement Plans

    If you’re not feeling great about your retirement fund, you’re not alone. Only two-thirds, or 67%, of Americans in their retirement planning years are confident about their prospects, according to Fidelity’s 2025 State of Retirement Planning report. This might appear optimistic, but it’s actually 7% less than last year. High Yield Savings Offers Powered by…

    Read More